Literature DB >> 59650

Membrane characteristics of established human T- and B-cell lines. Cross-reactivity of human T-antigenic determinants with peripheral lymphocytes of non-human primates and the presence of MLC antigens on cultured T-cell lines.

A Takada, H Babbitt, I Hayata, Y Takada.   

Abstract

Human T-cell lines (MOLT-4 and SOMMER-T) were injected into rabbits and monkeys (stumptail and squirrel monkeys). Rabbit anti-MOLT serum was absorbed with human liver and cultured B cells. Absorbed anti-MOLT serum was cytotoxic to lymphocytes of baboons and stumptail monkeys. Rabbit anti-MOLT and SOMMER-T sera after absorption with liver and B cell showed florescent ring formation in baboon and stumptail lymphocytes by using immunoflurescence techniques. On the other hand, antisera against MOLT and SOMMER-T cells in stumptail and squirrel monkeys were not only cytotoxic to MOLT and SOMMER-T cells, but also to other T-cell lines, CCRF-CEM and CCRF-HSB-2 cells. Cultured B-cell lines stimulated allogeneic and xenogeneic (rabbit and monkeys) lymphocytes far better than cultured T-cells lines did. T-cell lines, CCRF-HSB-2 and SOMMER-T (number 8402), gave small but significant stimulation to allogenic lymphocytes especially in the presence of foetal calf serum. MOLT-4B failed to stimulatie allogeneic lymphocytes. When lymphocytes of non-human primates and rabbit were cultured with human B- and T-cell lines in the presence of foetal calf serum, CCRF-HSB-2 and SOMMER-T cells stimulated xenogeneic lymphocytes of rabbit, squirrel monkey and stumptail monkey. MOLT-4 cells stimulated lymphocytes of baboon to some extent. These results indicate that although cultured B-cell lines had more mixed lyphocyte reaction (MLR) stimulating structure than T-cell lines, the latter still maintained some stimulating structure on the membrances.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 59650      PMCID: PMC1538515     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Cell surface markers for human T and B lymphocytes.

Authors:  G Brown; M F Greaves
Journal:  Eur J Immunol       Date:  1974-04       Impact factor: 5.532

Review 2.  Genetic control of immune responses.

Authors:  E Mozes; G M Shearer
Journal:  Curr Top Microbiol Immunol       Date:  1972       Impact factor: 4.291

3.  Serologic cross-reactivity between H-2 and HL-A antigens. I. Specific reactivity of rabbit anti-HL-A sera against murine cells.

Authors:  D Götze; S Ferrone; R A Reisfeld
Journal:  J Immunol       Date:  1972-09       Impact factor: 5.422

Review 4.  Histocompatibility-linked immune response genes.

Authors:  B Benacerraf; H O McDevitt
Journal:  Science       Date:  1972-01-21       Impact factor: 47.728

5.  A unique 'leukaemic' T lymphoid cell line: absence of stimulating effect in mixed lymphocyte reaction. Lack of MLR-S in leukaemic T lymphoid cells.

Authors:  T Han; J Minowada
Journal:  Clin Exp Immunol       Date:  1973-12       Impact factor: 4.330

6.  Failure of cultured human T-cell lymphoid lines to stimulate in mixed leukocyte culture.

Authors:  I Royston; P R Graze; R B Pitts
Journal:  J Natl Cancer Inst       Date:  1974-08       Impact factor: 13.506

7.  Shared antigenic determinants between human brain and human T-cell line.

Authors:  A Takada; Y Takada; U Ito; J Minowada
Journal:  Clin Exp Immunol       Date:  1974-12       Impact factor: 4.330

8.  B-cell alloantigens determined by the H-2 linked Ir region are associated with mixed lymphocyte culture stimulation.

Authors:  E C Lozner; D H Sachs; G M Shearer; W D Terry
Journal:  Science       Date:  1974-02-22       Impact factor: 47.728

9.  A mouse B-cell alloantigen determined by gene(s) linked to the major histocompatibility complex.

Authors:  D H Sachs; J L Cone
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

10.  I-region genes are expressed on T and B lymphocytes. Studies of the mixed lymphocyte reaction (MLR).

Authors:  P Lonai; H O McDevitt
Journal:  J Exp Med       Date:  1974-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.